ANCONA, Chiara
 Distribuzione geografica
Continente #
NA - Nord America 418
EU - Europa 118
AS - Asia 77
SA - Sud America 2
Totale 615
Nazione #
US - Stati Uniti d'America 414
IT - Italia 54
CN - Cina 34
SG - Singapore 28
DE - Germania 11
GB - Regno Unito 11
IE - Irlanda 10
RU - Federazione Russa 9
BE - Belgio 8
IN - India 8
CA - Canada 3
FI - Finlandia 3
FR - Francia 3
TR - Turchia 3
UA - Ucraina 3
BR - Brasile 2
IR - Iran 2
PL - Polonia 2
SE - Svezia 2
HK - Hong Kong 1
MT - Malta 1
MX - Messico 1
NL - Olanda 1
PH - Filippine 1
Totale 615
Città #
Fairfield 61
Chandler 50
Ashburn 34
Woodbridge 33
Ann Arbor 32
Wilmington 32
Singapore 28
Houston 21
Seattle 21
Palermo 17
Des Moines 16
Cambridge 14
Dublin 10
Medford 10
Brussels 8
Altamura 7
Beijing 7
Nanjing 7
Lawrence 6
Princeton 6
San Diego 6
Boardman 5
Kochi 5
Redwood City 5
Hebei 4
London 4
Ankara 3
Jinan 3
Ludwigshafen am Rhein 3
New York 3
Atlanta 2
Chicago 2
Frankfurt am Main 2
Guangzhou 2
Helsinki 2
Jacksonville 2
Los Angeles 2
Melfi 2
Ottawa 2
Seveso 2
Shenyang 2
Stockholm 2
Agrate Conturbia 1
Amsterdam 1
Bari 1
Castellana Grotte 1
Castelnuovo Rangone 1
Central District 1
Changsha 1
Clearwater 1
Dearborn 1
Duncan 1
Hangzhou 1
Hyderabad 1
Il-Madliena 1
Kashan 1
Kitzingen 1
Kumar 1
Leawood 1
Lucca 1
Macaé 1
Milan 1
Munich 1
Nanchang 1
Nürnberg 1
Orange 1
Phoenix 1
Pullach 1
Pune 1
Saint Petersburg 1
San Francisco 1
San Paolo di Civitate 1
Santa Clara 1
São Paulo 1
Taizhou 1
Tianjin 1
Toronto 1
Venice 1
Washington 1
Zhengzhou 1
Totale 523
Nome #
Gastric and Rectal Metastases from Malignant Melanoma Presenting with Hypochromic Anemia and Treated with Immunotherapy 174
Clinical Impact of Cystatin C/Cathepsin L and Follistatin/Activin A Systems in Breast Cancer Progression: A Preliminary Report 145
Gastric metastasis from breast cancer 104
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study 102
Circulating tumor DNA (ctDNA) as predictive biomarker in NSCLC patients treated with Nivolumab 74
Impressive objective response to nab-paclitaxel plus trastuzumab as fifth line therapy in aelderly her2-positive breast cancer patient 64
null 3
Totale 666
Categoria #
all - tutte 2.908
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.908


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202073 0 0 0 0 0 13 13 10 14 7 13 3
2020/2021124 4 7 3 26 9 8 6 7 14 18 15 7
2021/202271 2 14 0 3 7 4 5 1 10 7 4 14
2022/2023150 14 28 2 22 13 29 12 8 12 1 4 5
2023/202453 3 4 2 4 1 11 4 4 0 5 4 11
2024/202538 2 6 9 9 9 3 0 0 0 0 0 0
Totale 666